Neoplasia (United States)

SJR Rank #1,116H-index: 151SJR: 2.284Best quartile: Q1Open AccessAPC: US$3,530Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.61.21.82.4

Subject Categories

  • Cancer ResearchQ1

Areas: Biochemistry, Genetics and Molecular Biology

Most published research topics

Cancer, Hypoxia, and MetabolismCancer-related Molecular PathwaysCancer Cells and MetastasisEpigenetics and DNA MethylationAngiogenesis and VEGF in CancerProstate Cancer Treatment and ResearchUbiquitin and proteasome pathwaysGlioma Diagnosis and TreatmentCell Adhesion Molecules ResearchCancer Genomics and Diagnostics

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs075150225300

Documents per Year

2022202504080120160

Detailed Information

ISSN

1476-5586, 1522-8002

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

5.17

References per Document

54.84

Coverage

1999-2026

Scope

Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.

Metrics from SCImago Journal Rank 2025. View on SCImago